Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Gene expression profiling of thyroid tumors--clinical applicability.

Lubitz CC, Fahey TJ 3rd.

Nat Clin Pract Endocrinol Metab. 2006 Sep;2(9):472-3. No abstract available.

PMID:
16957755
2.

Using gene expression profiling to differentiate benign versus malignant thyroid tumors.

Mazzanti C, Zeiger MA, Costouros NG, Umbricht C, Westra WH, Smith D, Somervell H, Bevilacqua G, Alexander HR, Libutti SK.

Cancer Res. 2004 Apr 15;64(8):2898-903. Erratum in: Cancer Res. 2004 Jul 15;64(14):5028. Costourous N [corrected to Costouros NG].

3.

Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.

Montero-Conde C, Martín-Campos JM, Lerma E, Gimenez G, Martínez-Guitarte JL, Combalía N, Montaner D, Matías-Guiu X, Dopazo J, de Leiva A, Robledo M, Mauricio D.

Oncogene. 2008 Mar 6;27(11):1554-61. Epub 2007 Sep 17.

PMID:
17873908
4.

Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling.

Murphy KM, Chen F, Clark DP.

Hum Pathol. 2008 Mar;39(3):420-6. doi: 10.1016/j.humpath.2007.07.015.

PMID:
18261626
5.

Recent developments in the clinical application of thyroid cancer biomarkers.

Shibru D, Chung KW, Kebebew E.

Curr Opin Oncol. 2008 Jan;20(1):13-8. Review.

PMID:
18043251
6.

Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.

Zhao J, Leonard C, Gemsenjäger E, Heitz PU, Moch H, Odermatt B.

Oncol Rep. 2008 Feb;19(2):329-37.

PMID:
18202778
7.

Lessons from early clinical experience with the Afirma gene expression classifier.

Krane JF.

Cancer Cytopathol. 2014 Oct;122(10):715-9. doi: 10.1002/cncy.21472. Epub 2014 Aug 13. No abstract available.

8.

Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.

Siraj AK, Bavi P, Abubaker J, Jehan Z, Sultana M, Al-Dayel F, Al-Nuaim A, Alzahrani A, Ahmed M, Al-Sanea O, Uddin S, Al-Kuraya KS.

J Pathol. 2007 Oct;213(2):190-9.

PMID:
17703498
9.

Down-regulation of an inhibitor of cell growth, transmembrane protein 34 (TMEM34), in anaplastic thyroid cancer.

Akaishi J, Onda M, Okamoto J, Miyamoto S, Nagahama M, Ito K, Yoshida A, Shimizu K.

J Cancer Res Clin Oncol. 2007 Apr;133(4):213-8. Epub 2006 Oct 28.

PMID:
17072649
10.

Microarray analysis refines classification of non-medullary thyroid tumours of uncertain malignancy.

Fontaine JF, Mirebeau-Prunier D, Franc B, Triau S, Rodien P, Houlgatte R, Malthièry Y, Savagner F.

Oncogene. 2008 Apr 3;27(15):2228-36. Epub 2007 Oct 29.

PMID:
17968324
11.

Genome-wide studies in thyroid neoplasia.

Giordano TJ.

Endocrinol Metab Clin North Am. 2008 Jun;37(2):311-31, vii-viii. doi: 10.1016/j.ecl.2007.12.005. Review.

PMID:
18502329
12.

DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH.

Kresse SH, Skårn M, Ohnstad HO, Namløs HM, Bjerkehagen B, Myklebost O, Meza-Zepeda LA.

Mol Cancer. 2008 Jun 3;7:48. doi: 10.1186/1476-4598-7-48.

13.

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T.

Mod Pathol. 2008 Sep;21(9):1139-46. doi: 10.1038/modpathol.2008.105. Epub 2008 Jun 27.

14.

Molecular diagnosis of differentiated thyroid cancer. Towards the application in clinical practice.

Rousset B.

Ann Endocrinol (Paris). 2008 Apr;69(2):135-7. doi: 10.1016/j.ando.2008.02.011. Epub 2008 Apr 15. No abstract available.

PMID:
18417091
15.

MicroRNA expression profiles in thyroid tumors.

Nikiforova MN, Chiosea SI, Nikiforov YE.

Endocr Pathol. 2009 Summer;20(2):85-91. doi: 10.1007/s12022-009-9069-z. Review.

PMID:
19352602
16.

Clinical and molecular classification of hepatocellular carcinoma.

Llovet JM.

Liver Transpl. 2007 Nov;13(11 Suppl 2):S13-6. Review. No abstract available.

17.

Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.

Ulivieri A, Lavra L, Dominici R, Giacomelli L, Brunetti E, Sciacca L, Trovato M, Barresi G, Foukakis T, Jia-Jing L, Larsson C, Bartolazzi A, Sciacchitano S.

J Pathol. 2008 May;215(1):87-96. doi: 10.1002/path.2331.

PMID:
18306168
18.

Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.

Akaishi J, Onda M, Okamoto J, Miyamoto S, Nagahama M, Ito K, Yoshida A, Shimizu K.

BMC Cancer. 2006 Nov 1;6:260.

19.

cDNA microarrays: identification of gene signatures and their application in clinical practice.

Magic Z, Radulovic S, Brankovic-Magic M.

J BUON. 2007 Sep;12 Suppl 1:S39-44. Review.

PMID:
17935276
20.

Supplemental Content

Support Center